<SEC-DOCUMENT>0001213900-20-000798-index.html : 20200110
<SEC-HEADER>0001213900-20-000798.hdr.sgml : 20200110
<ACCEPTANCE-DATETIME>20200110172429
ACCESSION NUMBER:		0001213900-20-000798
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20191031
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200110
DATE AS OF CHANGE:		20200110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		20522025

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>f8k011020a1_aytubioscience.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM 8-K
<TEXT>
Document 1 - file: f8k011020a1_aytubioscience.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>f8k011020a1ex23-1_aytubio.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF THE ABBREVIATED FINANCIAL STATEMENTS OF THE PEDIATRICS PRODUCT PORTFOLIO OF CERECOR, INC.
<TEXT>
Document 2 - file: f8k011020a1ex23-1_aytubio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>f8k011020a1ex99-1_aytubio.htm
<DESCRIPTION>AUDITED HISTORICAL ABBREVIATED FINANCIAL STATEMENTS FOR THE PEDIATRICS PRODUCT PORTFOLIO OF CERECOR, INC. AS OF SEPTEMBER 30, 2019, AND DECEMBER 31, 2018 AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND THE YEAR ENDED DECEMBER 31, 2018
<TEXT>
Document 3 - file: f8k011020a1ex99-1_aytubio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>f8k011020a1ex99-2_aytubio.htm
<DESCRIPTION>UNAUDITED HISTORICAL ABBREVIATED FINANCIAL STATEMENTS FOR THE PEDIATRICS PRODUCT PORTFOLIO OF CERECOR, INC. AS OF SEPTEMBER 30, 2018 AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018
<TEXT>
Document 4 - file: f8k011020a1ex99-2_aytubio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>f8k011020a1ex99-3_aytubio.htm
<DESCRIPTION>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF JUNE 30, 2019 AND STATEMENT OF OPERATIONS FOR THE YEAR ENDED JUNE 30, 2019 AND THREE MONTHS ENDED SEPTEMBER 30, 2019
<TEXT>
Document 5 - file: f8k011020a1ex99-3_aytubio.htm

</DOCUMENT>
</SEC-DOCUMENT>